Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Manufacturing	246.76M	268.79M	325.02M	360.85M	276.53M
Pharmaceutical Manufacturing Growth	-8.19%	-17.30%	-9.93%	30.49%	-28.30%
Pharmaceutical Agent	409.41M	440.52M	430.29M	387.75M	361.71M
Pharmaceutical Agent Growth	-7.06%	2.38%	10.97%	7.20%	13.34%
Medical technology services and technology transfer	17.85M	10.87M	4.76M	34.20M	15.42M
Medical technology services and technology transfer Growth	64.28%	128.22%	-86.08%	121.82%	270.42%
Unallocated Other Operating Income	878.78K	862.97K	716.24K	684.82K	-
Unallocated Other Operating Income Growth	1.83%	20.49%	4.59%	-	-
Total	674.90M	721.03M	760.79M	783.48M	653.65M
Total Growth	-6.40%	-5.23%	-2.90%	19.86%	-7.80%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South China	291.43M	281.54M	287.00M	318.37M	259.02M
South China Growth	3.51%	-1.90%	-9.85%	22.91%	-19.50%
East China	162.89M	188.95M	175.73M	192.04M	151.54M
East China Growth	-13.79%	7.52%	-8.50%	26.72%	6.70%
Central China	89.58M	89.03M	124.67M	116.01M	101.96M
Central China Growth	0.62%	-28.59%	7.47%	13.78%	36.60%
North China	43.46M	45.07M	52.40M	56.18M	46.25M
North China Growth	-3.58%	-13.98%	-6.73%	21.47%	21.79%
Southwest China	31.21M	45.98M	50.89M	42.99M	32.85M
Southwest China Growth	-32.12%	-9.66%	18.37%	30.90%	-12.24%
Northwest China	34.46M	37.42M	40.99M	28.40M	26.06M
Northwest China Growth	-7.91%	-8.71%	44.34%	8.97%	-33.43%
Northeast China	20.09M	32.77M	29.09M	29.31M	22.85M
Northeast China Growth	-38.71%	12.68%	-0.77%	28.30%	-22.91%
Foreign	1.78M	264.15K	22.00K	177.37K	13.12M
Foreign Growth	574.11%	1100.74%	-87.60%	-98.65%	-50.24%
Total	674.90M	721.03M	760.79M	783.48M	653.65M
Total Growth	-6.40%	-5.23%	-2.90%	19.86%	-7.80%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 4, 2026

Data Sources Report a data error